Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: September 2013

Advanced Cell Technology, Inc. (ACTC) Starts Presentation at the Aegis Healthcare Conference

Advanced Cell Technology, Inc. is a biotechnology company that develops human embryonic and adult stem cell technology. The company has ownership/licensing of approximately 37 patents and approximately 190 patent applications pending in the regenerative medicine and stem cell therapy fields. … Continue reading

Posted in Aegis Conference | Leave a comment

OxySure Systems, Inc. (OXYS) to Exhibit Innovative Oxygen Technology at the Annual National Safety Council

OxySure Systems, a medical technology company that has pioneered an FDA-approved solution to produce medically pure oxygen from dry, inert powders for emergency and short duration use, will be an exhibitor at the National Safety Council’s (NSC) 2013 Congress & … Continue reading

Posted in OxySure Systems Inc. OXYS | Leave a comment

Alcobra Ltd. (ADHD) Starts Presentation at the Aegis Healthcare Conference

Alcobra Ltd. is an emerging biopharmaceutical company that develops and markets drugs for the treatment of central nervous system disorders and cognitive dysfunctions. The company is primarily focused on developing and marketing its most advanced drug, MG01CI, a non-stimulant attention … Continue reading

Posted in Aegis Conference | Leave a comment

Champions Oncology, Inc. (CSBR) Starts Presentation at the Aegis Healthcare Conference

Champions Oncology, Inc. offers technology solutions that personalize the development and use of oncology drugs. The company’s Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. Through this platform, … Continue reading

Posted in Aegis Conference | Leave a comment

Spectrum Pharmaceuticals, Inc. (SPPI) Starts Presentation at the Aegis Healthcare Conference

Spectrum Pharmaceuticals, Inc. is a biotechnology company engaged in acquiring, developing, and marketing prescription drug products for hematology and oncology. The company’s oncology products include FUSILEV for patients with osteosarcoma after high-dose methotrexate therapy; FOLOTYN, a folate analogue metabolic inhibitor … Continue reading

Posted in Aegis Conference | Leave a comment

OncoSec Medical Incorporated (ONCS) Starts Presentation at the Aegis Healthcare Conference

OncoSec Medical Incorporated (ONCS) OncoSec Medical Incorporated (OTC: ONCS) designs and develops novel cancer therapeutic products. The company’s products combine proprietary delivery technology with a novel DNA-based immunotherapeutics, known as OMS ElectroOncology. Its clinical programs include The NeoPulse approach, which … Continue reading

Posted in Aegis Conference | Leave a comment

Calpian, Inc. (CLPI) Targets Multiple Markets and Revenue Sources

In the U.S., Calpian, among other things, is a leader in a portion of the electronic payments industry known as merchant acquiring. Specifically, Calpian purchases recurring monthly income streams derived from credit card processing fees paid by U.S. retail merchants. … Continue reading

Posted in Calpian Inc. CLPI | Leave a comment

Wave Systems Corp. (WAVX) Named a “Visionary” in Gartner’s 2013 Mobile Data Protection Magic Quadrant

Wave Systems, the Trusted Computing Company and foremost expert on building security capabilities directly into endpoint computing platforms themselves, announced today that Gartner Inc. named the company a visionary in its September 2013 Magic Quadrant for Mobile Data Protection (MDP), … Continue reading

Posted in Small Cap News | Leave a comment

Infinity Resources Holdings Corp. (IRHC) Subsidiary Details Economic Benefits of Food Waste Recycling at Arkansas Recycling Coalition

Brian Dick, CEO of Quest Resource Management Group, an Infinity Resources Holdings Corp. company, Tuesday spoke at the Arkansas Recycling Coalition, emphasizing the economic benefits of food waste and discussing the evolution of food waste recycling in the United States. … Continue reading

Posted in Small Cap News | Leave a comment

Heat Biologics, Inc. (HTBX) Starts Presentation at the Aegis Healthcare Conference

Heat Biologics, Inc. is a biopharmaceutical company developing cellular therapeutic vaccines for cancers and infectious diseases. The company is developing the Immune Pan Antigen Cytotoxic therapy, a platform technology that delivers human cells that are reprogrammed to pump out various … Continue reading

Posted in Aegis Conference | Leave a comment